Abstract:CD147 also known as EMMPRIN, basigin, and HAb18G, is a single-chain type I transmembrane protein shown to be overexpressed in aggressive human cancers of CNS, head and neck, breasts, lungs, gastrointestinal, genitourinary, skin, hematological, and musculoskeletal. In these malignancies, the molecule is integral to the diverse but complimentary hallmarks of cancer: it is pivotal in cancerous proliferative signaling, growth propagation, cellular survival, replicative immortality, angiogenesis, metabolic reprogramming, immune evasion, invasion, and metastasis. CD147 also has regulatory functions in cancer-enabling characteristics such as DNA damage response (DDR) and immune evasion. These neoplastic functions of CD147 are executed through numerous and sometimes overlapping molecular pathways: it transduces signals from upstream molecules or ligands such as cyclophilin A (CyPA), CD98, and S100A9; activates a repertoire of downstream molecules and pathways including matrix metalloproteinases (MMPs)-2,3,9, hypoxia-inducible factors (HIF)-1/2α, PI3K/Akt/mTOR/HIF-1α, and ATM/ATR/p53; and also functions as an indispensable chaperone or regulator to monocarboxylate, fatty acid, and amino acid transporters. Interestingly, induced loss of functions to CD147 prevents and reverses the acquired hallmarks of cancer in neoplastic diseases. Silencing of Cd147 also alleviates known resistance to chemoradiotherapy exhibited by malignant tumors like carcinomas of the breast, lung, pancreas, liver, gastric, colon, ovary, cervix, prostate, urinary bladder, glioblastoma, and melanoma. Targeting CD147 antigen in chimeric and induced-chimeric antigen T cell or antibody therapies is also shown to be safer and more effective. Moreover, incorporating anti-CD147 monoclonal antibodies in chemoradiotherapy, oncolytic viral therapy, and oncolytic virus-based-gene therapies increases effectiveness and reduces on and off-target toxicity. This study advocates the expedition and expansion by further exploiting the evidence acquired from the experimental studies that modulate CD147 functions in hallmarks of cancer and cancer-enabling features and strive to translate them into clinical practice to alleviate the emergency and propagation of cancer, as well as the associated clinical and social consequences.

Effects of CD147 on Proliferation, Migration, and Invasion of Lung Cancer A549 Cells

Effects of Fibroblasts-Colorectal Cancer Cells Interaction on EMMPRIN Expression in Colorectal Cancer Cells

[Increased Expression of Extracellular Matrix Metalloproteinase Inducer Through Interaction Between Fibroblasts and Colonic Cancer Cells].

CD147 promotes proliferation and migration of oral cancer cells by inhibiting junctions between E-cadherin and β-catenin

Expression of extracellular matrix metalloproteinase inducer CD147 and MMP-9 in hepatocellular carcinoma and its clinical significance

Extracellular matrix metalloproteinase inducer (CD147/BSG/EMMPRIN)-induced radioresistance in cervical cancer by regulating the percentage of the cells in the G2/m phase of the cell cycle and the repair of DNA Double-strand Breaks (DSBs).

Involvement of CD147 in Regulation of Multidrug Resistance to P‐gp Substrate Drugs and in Vitro Invasion in Breast Cancer Cells

CD147 silencing via RNA interference reduces tumor cell invasion, metastasis and increases chemosensitivity in pancreatic cancer cells.

Silencing of CD147 inhibits cell proliferation, migration, invasion, lipid metabolism dysregulation and promotes apoptosis in lung adenocarcinoma via blocking the Rap1 signaling pathway

CD147 promotes collective invasion through cathepsin B in hepatocellular carcinoma

The expression of CD147 and PTEN in non small cell lung cancer and their correlation with clinical pathological factors

CD147: an integral and potential molecule to abrogate hallmarks of cancer

Expression and CD147,MMP-9 and P-Erk in Invasive Ductal Carcinoma of Breast and Its Significance

Inhibition Of Cd147 Gene Expression Via Rna Interference Reduces Tumor Cell Invasion, Tumorigenicity And Increases Chemosensitivity To Cisplatin In Laryngeal Carcinoma Hep2 Cells

Studies on the effect and mechanism of CD147 on melanoma stem cells

Large-Scale Single-Cell and Bulk Sequencing Analyses Reveal the Prognostic Value and Immune Aspects of CD147 in Pan-Cancer

Relationship Between the Expression of P-gp and that of CD147, MMPs in None Small Cell Lung Cancer

ERK1/2 Signalling Pathway is Involved in CD147-mediated Gastric Cancer Cell Line SGC7901 Proliferation and Invasion

CD151 drives cancer progression depending on integrin α3β1 through EGFR signaling in non-small cell lung cancer

CD147 overexpression promotes tumorigenicity in Chinese hamster ovary cells

Overexpression of CXCL17 increases migration and invasion of A549 lung adenocarcinoma cells